Enhanced platelet serotonin 5-HT(2A) receptor binding in anorexia nervosa and bulimia nervosa

European Neuropsychopharmacology

Volumn 9, Issue 6, 1999, Pages 469-473

  Spigset, Olav ^a,b   Andersen, Tonny ^a   Hägg, Staffan ^a   Mjörndal, Tom ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anorexia nervosa; Bulimia nervosa; Platelets; Serotonin; Serotonin receptors

Indexed keywords

LYSERGIDE; SEROTONIN 2A RECEPTOR;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY MASS; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0033397636     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(99)00012-7     Document Type: Editorial

References (29)

1. Diagnostic and statistical manual of mental disorders. 4th ed. (DSM-IV) :1994;American Psychiatric Association Press, Washington DC.
2. Andres A.H., Rao M.L., Ostrowitski S., Entzian W. Human brain cortex and platelet serotonin-2 receptor binding properties and their regulation by endogenous serotonin. Life Sci. 52:1993;313-321.
3. 3 H-LSD in the blood platelets of depressed patients. Life Sci. 44:1989;725-734.
4. Brewerton T.D. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology. 20:1995;561-590.
5. Brewerton T.D., Jimerson D.C. Studies of serotonin function in anorexia nervosa. Psychiatry Res. 61:1996;31-42.
6. Brewerton T.D., Mueller E.A., Lesem M.D., Brandt H.A., Quearry B., George D.T., et al. Neuroendocrine responses to m-chlorophenylpiperazine and L-tryptophan in bulimia. Arch. Gen. Psychiatry. 49:1992;852-861.
7. 2A gene promoter polymorphism and anorexia nervosa. Lancet. 350:1997;412.
8. 2A receptor. J. Neurochem. 63:1994;465-469.
9. 125 I]iodolysergic acid diethylamide binding in human frontal cortex and platelet tissue. J. Neurochem. 53:1989;191-196.
10. 2A promoter polymorphism - 1438G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet. 351:1998;1785-1786.
11. Goldbloom D.S., Hicks L.K., Garfinkel P.E. Platelet serotonin uptake in bulimia nervosa. Biol. Psychiatry. 28:1990;644-647.
12. Hamik A., Peroutka S.J. 1-(m-chlorophenylpiperazine) interactions with neurotransmitter receptors in the brain. Biol. Psychiatry. 25:1989;569-575.
13. 2 -adrenoceptor and adenylate cyclase in patients with anorexia nervosa and bulimia. J. Clin. Endocrinol. Metab. 61:1985;1053-1060.
14. Hinney A., Barth N., Ziegler A., von Prittwitz S., Hamann A., Henninghausen K., et al. Serotonin transporter gene-linked polymorphic region: allele distribution in relationship to body weight and in anorexia nervosa. Life Sci. 61:1997;PL295-PL303.
15. Kaye W., Gendall K., Strober M. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa. Biol. Psychiatry. 44:1998;825-838.
16. Levitan R.D., Kaplan A.S., Joffe R.T., Levitt A.J., Brown G.M. Hormonal and subjective responses to intravenous meta-chlorophenylpiperazine in bulimia nervosa. Arch. Gen. Psychiatry. 54:1997;521-527.
17. Lowry D.H., Rosenbrough H.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
18. Marazziti D., Macchi E., Rotondo A., Placidi G.F., Cassano G.B. Involvement of serotonin system in bulimia. Life Sci. 43:1988;2123-2126.
19. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:1978;206-210.
20. McBride P.A., Anderson G.M., Khait A.D., Sunday S.R., Halmi K.A. Serotonergic responsivity in eating disorders. Psychopharmacol. Bull. 27:1991;365-372.
21. Okamoto Y., Okamota Y., Kagaya A., Tamiya S., Fujita Y., Tohoda Y., Motohashi N., Yamawaki S. Serotonin-induced platelet calcium mobilization is enhanced in bulimia nervosa but not in anorexia nervosa. Biol. Psychiatry. 38:1995;274-276.
22. 3 H] lysergic acid diethylamide binding in seasonal affective disorders and the effect of bright light therapy. Biol. Psychiatry. 45:1999;464-470.
23. 2A promoter polymorphism in anorexia nervosa. Lancet. 351:1998;1785.
24. 3 H]LSD): intra- and interindividual variability. Neuropsychopharmacology. 16:1997;285-293.
25. 3 H]paroxetine to serotonin uptake sites in platelets from healthy volunteers. Biol. Psychiatry. 43:1998;774-780.
26. 2 receptor binding sites re-evaluated: a criticism of recent techniques. J. Neural Transm. 92:1993;11-24.
27. 3 H]imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sci. 38:1986;1235-1242.
28. Wolfe B.E., Metzger E., Jimerson D.C. Research update on serotonin function in bulimia nervosa and anorexia nervosa. Psychopharmacol. Bull. 33:1997;345-354.
29. Zemishlany Z., Modai I., Aptrer A., Jerushlamy Z., Samuel E., Tyano S. Serotonin (5-HT) uptake by blood platelets in anorexia nervosa. Acta Psychiatr. Scand. 75:1987;127-130.